2024-02-26
Persistent HIV-1 controllers
Infectiology
In persistent controllers, HIV-1 control is maintained indefinitely in the absence of antiretroviral therapy. In transient controllers, virological control is only temporary. In this study, researchers assessed the HIV-1 reservoir in these two phenotypes to identify factors predicting HIV progression. In both phenotypes, total, intact and defective proviruses were found in lower quantities than in patients on antiretroviral therapy. Intact provirus levels were lower in persistent than in transient controls. The ratio of intact to defective HIV-DNA was significantly higher in transient controls.
Last press reviews
Monitoring sewers to track cancer: an emerging avenue
By Elodie Vaz | Published on March 25, 2026 | 4 min read<br><br><br>...
Colorectal cancer: is the risk on the plate?
By Ana Espino | Published on March 25, 2026 | 3 min read<br><br><br>...
Nutrition for optimizing immune function and recovery from injury in sports
By Ana Espino | Published on March 24, 2026 | 3 min read<br><br><br>...